Skip To Content

Study ID: ACCRU Can Stem 303C Boston Biomedical CanStem303C (aka BB608-303CRC)

Title:

A Phase III Study of BBI-608 in combination with 5 Flourouracil, Leucovorin, Irinotecan (Folfiri) in Adult Patients with Previously treated Metastatic Colorectal Cancer.

Description:
The CanStem303C Trial
Location:
Sioux Falls Region
Principal Investigator:
Jonathan Bleeker, MD
Disease:
Colorectal
Stage:
Phase III
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.